The Congress, which is organised by Improve International, has separate streams for small animal medicine and small animal surgery and a dedicated veterinary nursing stream.
There will also be an exhibition of the latest innovations in veterinary products and services running alongside the lectures.
Helen Richmond, Head of Publishing at Improve said: “While technological innovation has made online congresses much more engaging and accessible over the last year, we felt the time was right to bring Vets North back in a face-to-face environment. Many of our previous delegates have already told us how much they are looking forward to being able to learn and enjoy some social time together again.
“As usual this year’s programme will include presentations and lectures from global experts, who will give advice and share knowledge that can be implemented in practice immediately. We would like to thank Elanco as our lead sponsor of this year’s Vets North and we also thank our other partners and sponsors for their support and loyalty during this difficult year.”
"Naturally, keeping delegates safe is our highest priority so we are working with the venue to ensure that the Government’s recommendations are implemented to the full and that Haydock Park is a COVID-secure venue.”
Early Bird tickets are available until the end of June.
For more information visit www.vetsnorth.com or call 01793 20805.
A new study published in Equine Veterinary Journal's (EVJ) in partnership with the American Association of Equine Practitioners, has shown that a wireless, inertial sensor-based system can effectively measure a horse's response to a flexion test.
The authors say that opinions on the value of flexion tests in assessing equine lameness have been divided for many years, but their research should turn what has always been regarded as a subjective process into a wholly objective one.
Flexion tests are used routinely in horses with subtle or imperceptible lameness, to exacerbate the problem and make it apparent to the observer. The test involves applying a short period of pressure to the joints of the limb before re-examination, and evaluating any change in gait. However, flexion tests rely on the ability of the observer to identify and interpret changes in the horse's gait and in that respect these tests are subjective and not necessarily consistent between observers.
The research study was conducted by orthopaedic surgeons based at the University of Glasgow's School of Veterinary Medicine1. A total of 17 healthy adult horses, all in work, were fitted with sensors before being trotted in a straight line. The sensors measured vertical pelvic movement asymmetry for both right and left hind limb strides and the average difference in maximum and minimum pelvic height between right and left hind limb strides. A hind limb was randomly selected for 60 seconds of proximal flexion, after which the horse was trotted for a minimum of 10 strides. Response to the flexion was blindly assessed as negative or positive by an experienced observer.
John Marshall, lecturer in equine surgery at the University of Glasgow, who led the study, said: "A positive response to flexion resulted in significant changes to objective measurements of pelvic symmetry, supporting the use of inertial sensor systems to objectively assess response to flexion tests."
Professor Jim Moore, North American Editor of the EVJ, said: "The introduction of an objective approach to documenting lameness examination will not only help vets and trainers to investigate equine lameness more accurately. It will also serve as an unbiased method of communicating lameness examination findings among vets, trainers, farriers and other professionals."
The next phase of research will be to establish cut-off values for objective assessment of other equine lameness diagnostic procedures, such as nerve blocks.
Reference
The survey is the second stage of a three stage review recommended to RCVS Council by the College’s Standards Committee in 2019, after it looked at the implications of new technologies for both animal welfare and veterinary regulation.
The main areas under consideration include the provision of 24/7 emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon. The review also encompasses remote consulting.
In stage one of the review, the RCVS commissioned a research agency to conduct a series of focus group discussions with veterinary professionals working in a variety of roles and sectors. The information gleaned from the discussions was then used to develop the questions for this survey.
The survey will ask veterinary professionals to reflect on what, for them, should underpin good regulations and guidelines for practice.
It will then ask respondents how these principles should be applied in particular situations relating to 24/7 emergency cover and 'under care' before inviting their views on how they would like regulations on these two areas to deal with any tensions between different desirable regulatory aims.
The survey results will be used to help produce any changes to the RCVS Code of Professional Conduct and its supporting guidance concerning ‘under care’ and the provision of 24/7 emergency cover, which will then be put out for full public consultation later this year.
Chair of the RCVS Standards Committee, Dr Melissa Donald, said: “This review addresses fundamental questions about how we should continue to interpret ‘under care’ in a profession, and a society, that is largely unrecognisable to the one that first defined the term, and, at the same time, how we can continue to provide 24/7 emergency cover for those animals under our care.
“The original Vet Futures report also emphasised the impact that technological advances may have on the veterinary professions, so we must ensure we have in place a regulatory framework that gives consideration to these potential changes whilst ensuring animal health and welfare remain at its heart.
“These are challenging but hugely important questions on which we are hoping to receive as much feedback as possible. I do understand the huge pressures my vet and vet nurse colleagues continue to work under at the moment, so would like to thank them in advance for taking a little time out of their busy days to send us their views.”
The survey will open on Wednesday, 19th May 2021 for all UK-based veterinary surgeons and veterinary nurses.
All responses will be used and reported anonymously, so respondents will not be identified.
The survey will be open for four weeks, closing at 5pm on Wednesday, 16 June 2021.
It should take 15-20 minutes to complete, but can be returned to and completed in stages if preferred.
Further background information about the Under Care Review is available at www.rcvs.org.uk/undercare.
Whilst you're there, the company will doubtless use the opportunity to bend your ear about how its technology can save time, drive revenue, and strengthen patient care.
Still, all in a good cause, and the company says it expects to be making a significant donation towards supporting members of the veterinary community who are experiencing financial and mental health challenges.
ezyVet Chief Growth Officer Pete Brown said: ““As innovators in the veterinary software space, we’re passionate about bettering the lives of veterinary professionals and we recognise the critical work Vetlife is doing to support the hard-working veterinary community.
"We’re going to be donating £1 to Vetlife for every person that visits the ezyVet booth at the London Vet Show, so we encourage everyone to come down and help us support this very worthwhile cause.”
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors VetCell, in conjunction with their UK laboratory partner Biobest, were officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, Chief Operating Officer of VetCell Bioscience said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
According to the company, there is considerable interest from the human sector and studies in human medicine, for the treatment of Achilles tendinopathies, could begin as early as next year.
The recommendation follows the analysis of data collected as part of the company's Talk About Laminitis disease awareness initiative, which has seen more than 47,000 horses tested for PPID since it was launched in 20121.
The data revealed that, regardless of presenting clinical signs, a horse aged 15-20 is three times more likely to have PPID compared to a horse under 10, and this risk increases with age. For example, a horse of 20-25 is six times more likely to have PPID compared to a horse under 10 and a horse that is 25-30 is 10 times more likely to have PPID.
Boehringer says that despite the high prevalence of PPID in the older horse population, the clinical signs of the disease are insidious in onset and owners may simply associate them with the ageing process.
One study demonstrated that in a single population of horses over the age of 15 only 1.6% of owners reported signs of PPID2. However, when the same group of horses were examined by a veterinary surgeon, 21% were found to have signs of the disease.
Dr Jo Ireland, veterinary surgeon at the University of Liverpool, said: "It is often difficult for owners to spot the signs of PPID as they frequently associate them with the ageing process. However, PPID is now the fifth most commonly diagnosed disease in horses in the UK3.
"We are therefore encouraging veterinary surgeons to routinely test horses over 15 years of age or those that are displaying signs of PPID with an ACTH test."
The 'Talk About Laminitis' disease awareness initiative runs from June until the end of October and aims to raise awareness of the underlying hormonal causes of laminitis – PPID and Equine Metabolic Syndrome (EMS). As part of the scheme, the laboratory fees for the blood test which detects PPID (the basal ACTH test) are free.
Redwings’ head of veterinary and care, senior veterinary surgeon Nicky Jarvis, said: "Any initiative that decreases the incidence of laminitis developing in an older equine is invaluable. Laminitis is an extremely distressing condition for both the horse and the owner and the long-term consequences can be devastating. Knowing the underlying cause is a huge help in tackling the disease and we would encourage anyone to take advantage of this offer and get their veteran checked out."
For further information about 'Talk About Laminitis', visit www.talkaboutlaminitis.co.uk or contact your local Boehringer Ingelheim account manager.
References
Judges for the UK Rabbit Vet of the Year, the Rabbit Nurse of the Year and the Rabbit Veterinary Practice of the Year awards will be looking for exceptional knowledge of rabbit care and husbandry, and evidence of the winners’ continued commitment to educating the public on how to care for rabbits correctly.
Dr Suzanne Moyes MVB MRCVS, awards judge and Veterinary Director at Burgess Pet Care said: "These awards are our way of saying ‘Thank You’ to the veterinary professionals that are helping to improve the lives of pet rabbits."
Rae Todd, Director of the Rabbit Welfare Association & Fund said: "Rabbits make absolutely fantastic pets but research continues to show that there are still too many rabbit owners failing to meet the correct needs of their rabbits. We’re incredibly grateful for the growing number of vets that are working hard to address this, whether that’s by utilising the available rabbit CPD, taking part in events like Rabbit Awareness Week or generally making their practices more suitable environments for rabbit-owning clients."
Veterinary surgeons and nurses can self-nominate for these awards, and nominations are also being sought from the public.
The winners will each receive a cash prize of £500.
To enter the awards, visit www.burgesspetcare.com/excel-vet-awards.
Q Fever is caused by the bacterium Coxiella burnetii, which can infect humans, cattle, goats, sheep and many other mammals, as well as reptiles, ticks and birds.
Known originally as Query fever, it was first identified in Australia in 1935 after an outbreak of disease in abattoir workers.
Ceva says half of UK dairy farms may be at risk of Q Fever1, 2.
The webinar, which will be presented by Jonathan Statham MA VetMB DCHP FRCVS (pictured right), an RCVS-registered specialist in cattle health and co-author of the ‘Dairy Herd Health’ textbook, will count towards 1.5 hours of CPD.
It will cover the UK prevalence of Q Fever in herds, its cause and transmission, together with identification and diagnostics.
It will also look at the variations between livestock species, disease prevention and its risk to humans as a zoonosis.
Jonathan said: "Q Fever is of much higher profile in many other parts of the world such as Australia and has been notifiable for some years with national testing programmes in a number of European countries such as Germany.
“Recently Q Fever has become notifiable in the UK and climate change is changing the future risk profile."
Renzo Di Florio, veterinary advisor at Ceva said: “The disease causes issues with reproduction and fertility and has the potential to have significant impact on livestock health and productivity.
"However, awareness is low amongst the farming industry.
“Our Q Fever webinar will help raise awareness of the disease and the preventative measures that can be put in place to help protect those working with livestock on a regular basis and reduce the impact of Q Fever on farms.
To register for the webinar or if you have further questions, e-mail cevauk-webinars@ceva.com
AmpliSpec LAB Mastitis uses isothermal amplification technology, which means laboratories can use less expensive equipment.
It also uses the company's lyophilised bead platform, designed to make the test stable and easy to use.
Biotangents says its new test will offer notable cost, speed and accuracy benefits over the traditional culture and PCR testing used by animal health laboratories and veterinary clinics around the world.
CEO Fiona Marshall said: “With 93% sensitivity and 95% specificity, this is a highly sophisticated assay that will help farmers, vets and laboratories to better treat mastitis.
http://www.biotangents.co.uk
Polypropylene or plastic-based wipes, which have been industry standard due to their reliable nature and compatibility with biocidal active materials, are due to be banned in the UK, because they take up to 100 years to break down.
Byotrol says its new wipes are made using a plastic-free 100% biodegradable substrate that deteriorates 3 months after disposal.
The company adds that the new wipes are proven to destroy bacteria, yeast, enveloped viruses, and fungi on non-porous surfaces and are effective against animal-specific pathogens such as: Brucella canis, Streptococcus equi, Staphylococcus aureus, Salmonella typhimurium, Bordetella bronchiseptica, Coronaviruses, Feline Immunodeficiency Virus (FIV), and Microsporum canis and Trichophyton mentagrophytes
Jane Kiely, Head of Marketing at Byotrol said: “Launching the Anigene Professional Surface Disinfectant Wipes is the final step in removing plastic wet wipes from our portfolio and a significant milestone in Byotrol’s sustainability journey.
"We are proud to be at the forefront of sustainability in the veterinary industry, offering an effective and regulatory-compliant product range that meets the needs of our customers”
Byotrol will be on Stand F18 at the London Vet Show.
https://byotrol.com
The UK's first online gastric ulcer risk assessment for horse owners has just been launched as part of the 2009 Gastric Ulcer Awareness Month (GUAM), organised by Merial Equine Health.
Merial has developed the risk online questionnaire to enable owners to evaluate their horse's risk of ulcers. By logging on to the website http://www.gastriculcerrisk.co.uk/, owners, trainers and riders can complete a form which then returns the results via email. Where an animal is considered to be at medium to high risk, owners will be advised to consult their veterinary practice.
The company's Dr Emma Batson said: "Since the first GUAM in 2007, significant progress has been made in developing awareness and understanding of equine gastric ulcer syndrome.
"However there is still more to do! Our goal is to move gastric ulcers further up the diagnostic process, such that the condition is an early consideration for all horses presented with the vague symptoms associated with ulceration. We know that due to the vague nature of the symptoms, many of horses are suspected of other ailments such as back and teeth problems, general poor performance, or behavioural issues prior to being diagnosed with ulcers.
"This new initiative has been developed through consultation with practising internal medicine specialists. We hope it will help to highlight more cases and encourage clients into the practice with horses that are at genuine risk of ulcers. Further diagnosis, treatment and management measures can then be considered in consultation with the client.
"The website also has a veterinary page so that follow up information and any gastroscopy results can be recorded by the vet. We hope that this feedback will help generate some valuable data for the industry."
To help you promote this initiative, Merial has produced an impactful poster for use in practice waiting rooms, along with educational literature. The poster will be available as a loose insert in various publications during April and May.
For those practices which require a referral scoping service, Merial can put you in touch with three specialist consultants; Rachael Conwell (North) Dr.Tim Brazil (Midlands/nationwide) and Richard Hepburn (South West) who each provide a mobile scoping clinic.
Merial is also promising support for the mobile scoping service for the five practices that direct the largest number of clients to http://www.gastriculcerrisk.co.uk/
A number of events are also taking place during the month for vets, trainers and horse owners, including the following CPD events:
GUAM is supported by BEVA and Dr Batson hopes that the 2009 initiatives will further boost awareness, understanding and diagnosis of this underrated condition.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The company says its service has been designed to help practices take a proactive approach to managing their workforce, keeping them out of the employment tribunal and providing continued support to help them achieve their goals.
Melanie Davies, Head of Employment at MS Rubric (pictured right) said: "Whether a business employs 5 people or 500, is a start-up, or has been successfully trading for years, it is critical that it has a reliable legal advisory system in place to manage the range of challenges that arise.
"All businesses need to be able to access a professional source of advice and guidance to meet their objectives for best practice, compliance or to meet commercial goals and targets.
"With legislation changing so frequently, this legal expertise is sometimes missing from some businesses. As business owners realise its importance, they are relying more on external HR and legal experts like ourselves to provide this service. We think it’s so important, we are making this available to all sectors of business.”
MS Rubric adds that all its advice is covered by legal professional privilege. This means that unlike when businesses use HR or other consultancies, conversations between MS Rubric and its clients remain confidential and disclosure is not required.
For more information, contact Melanie Davies on 01454 800008 or mel.davies@msrubric.co.uk.
Normally only accessible by ISFM members, the channel has been opened up as a free resource to help vets keep on top of CPD and includes over 40 webinars presented by internationally recognised veterinary specialists.
Topics include: anaesthesia and analgesia, behaviour, emergency and critical care, feline medicine and neurology. Each webinar is worth 1 hour of CPD and you get a certificate.
The channel includes a new webinar: ‘COVID-19 – helping cats cope’ which looks at how you can advise owners to help their cats deal with changes at home.
ISFM’s Feline Medicine Consultant, Sam Taylor said: "ISFM is committed to educating veterinary professionals on all things feline, so we are delighted to be able to bring some of our normally member-only benefits to a wider audience during this challenging time."
To register for the ISFM webinar channel, visit: https://icatcare.org/event/isfm-vet-webinars/
Tara Evans RVN from Vita said: "We wanted to raise awareness and start a discussion with rabbit owners about preventative ear care in rabbits, including how and when owners are cleaning their rabbits’ ears.”
91% of owners also agreed that cleaning is important for rabbits with ear health problems, but 49% have never cleaned their rabbit’s ears.
For the remainder, the most common reason owners gave for cleaning their rabbits’ ears was as a preventative measure (46%), followed by noticing signs of discomfort (25%) and following veterinary advice (25%).
Tara added: “These results show us that owners are aware cleaning their rabbits’ ears is important which leaves us plenty of opportunities to educate on what owners should be looking out for.
"The survey showed that 57% of rabbit owners correctly identified lop ears to be a risk factor in ear health yet a contradictory 28% thought straight ears posed more of a risk.
"It is our job as veterinary professionals to share facts and impart our knowledge to our engaged audience.”
The survey looked into different options available for ear cleaning and identified that 51% of respondents would choose ear wipes, 25% home prepared solutions and 31% a designated rabbit ear cleaning product.
Tara said: “We want to be encouraging owners to be looking at their rabbits’ ears and cleaning them, however wipes can fail to provide a thorough clean and reach the deeper ear canal effectively, and homemade remedies may be irritating to rabbit ears.
"It is important to use an ear cleaner which is designed for and safe to use in rabbits, such as Omniotic.
"Our survey underscores the critical need for increased education and awareness surrounding rabbit ear health.
"It's essential for owners to understand the significance of regular ear cleaning in maintaining overall wellness and preventing potential diseases.”
www.vitaanimalhealth.com
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
Supreme Petfoods Ltd has published the results of tests on small animal petfood which, according to the company, highlight significant problems with the on-pack declarations and contents of a number of the leading brands.
The tests, which were carried out by Campden BRI on behalf of Supreme Petfoods, discovered:
Issues regarding high sugar levels which are not required to be declared under current rules. The highest average levels of sugar were found in Wagg Optimum (4.57%), Beaphar Care + (5.00%), Burgess Supa Fruiti (5.10%), Beaphar Extra Vital (5.35%) and Burgess Excel (4.04%).
In the company's press release, Chris Childs, Managing Director of Supreme Petfood, commented: "The results greatly concerned us. We were shocked to find food that is marketed for rabbits - ie: herbivores - had traces of mammalian and avian DNA in it. In my opinion, this can only be compared to vegetarian food being contaminated with meat. This was our main concern amongst many other issues revealed."
That strikes me as overstating the case somewhat. Aside from the fact that bunnies don't get quite as het up about their diets as vegans, the report does not define what 'trace DNA contamination is'. Going on the shock expressed by Mr Childs, I'm expecting a pork chop or a drumstick in every bag of Burgess Excel at the very least.
Molly Varga, BVetMed, DZooMed (Mammalian), MRCVS told VetSurgeon.org that she would expect rabbits to be exposed to trace amounts of animal DNA naturally and that the amounts found in the tests were not likely to have any effect whatsoever on the health of rabbits. Nevertheless, she did feel that the report highlighted important issues concerning the fibre and sugar content of various diets.
As a consequence of the report, Supreme Petfoods is calling for an overhaul of the rules and regulations which apply to pet food for small companion animals. The company suggests the introduction of an accredited quality scheme aimed specifically at pet food for small companion animals, containing strict conditions for the production, packaging and marketing of food for herbivores.
In response, Burgess Pet Care issued a statement expressing considerable reservations as to the timing, purpose and potential negative outcome for the welfare of pet rabbits of Supreme's report. Commenting on behalf of Burgess, Sharon Redrobe, Head of Veterinary Services, Bristol Zoo Gardens, and Head of Rabbit Clinic, Bristol, said: "Any research into small animal health should focus on the crucial role of fibre in a balanced feeding plan and how this can be communicated to rabbit owners, so discussions centring around the detailed contents of pellets are irrelevant in my opinion to this central welfare issue."
To read Supreme's report, click here.
Vétoquinol, the makers of Zylkène, is offering the chance for a veterinary professional to receive a bursary towards the Centre of Applied Ethnology (COAPE) Behaviour Diploma, worth £5000.
The company says behavioural training offers a wealth of benefits to veterinary practices and staff, including safer pet handling, improved client loyalty and a more comfortable environment for animals, as well as the opportunity to help increase the clinic's income.
The COAPE Behaviour Diploma is designed to help professionals further their knowledge of behavioural issues and gives them the skills to deal with situations that may arise during the course of their work. It is broken down into 3 one-year-long courses, each costing £5000.
Jodie Foster of Haygate Vets in Telford was the recipient of last year's bursary and has since been voted the VN Times Welfare Nurse of the Year. She said: "I'd been interested in doing this course for some time, so it was amazing to hear that I'd been selected. I have found it challenging at times, but it's also been very rewarding and has really helped to improve my confidence when dealing with behavioural situations at work.
"The course tutors were fantastic and really fuelled my desire to further develop my knowledge of animal behaviour. The course definitely contributed to being awarded the prize from VN Times so I would strongly recommend that anyone with an interest in pet behaviour applies for the bursary."
To apply, complete the application form at www.zylkenepet.co.uk/COAPE by 10 August 2014, explaining why you want to further your knowledge of animal behaviour and what you hope to achieve on completing the course.
In his new role, Ian will guide the development of interventions, strategies, process changes and campaigns to improve responsible pharmaceutical usage across Mars Veterinary Health’s 2,500+ global veterinary clinics.
Ian was previously Head of Internal Medicine at Hertfordshire-based Davies Veterinary Specialists and antimicrobial resistance (AMR) subject matter expert on the clinical board of Linnaeus.
Mars says that this new role is one of several actions it is taking to promote pharmaceutical stewardship and combat antimicrobial resistance, include the implementation of a formal responsible pharmaceutical stewardship programme across all its veterinary clinics globally during the next several years.
Ian said: “As one of the leading providers of veterinary care in the world, we have a unique opportunity – and responsibility – to lead the way toward a more sustainable profession.
“Antimicrobial resistance is a critical One Health issue, and I look forward to continue working with colleagues across more than 2,500 clinics to support responsible antibiotic prescribing.
"Energy and interest in this area is growing profession-wide, demonstrating a reassuring recognition of how we can make meaningful improvements for people, pets, and the planet long into the future.”
The 10 minute survey seeks to capture the current level of understanding and feelings around the deployment of AI tools across the veterinary industry.
VetCT says the purpose of the survey is to start some discussion and identify areas where training and support could help veterinary practitioners.
Julien Labruyère, Chief Innovation Officer at VetCT (pictured), said: “AI is here to stay and will increasingly become part of all aspects of veterinary medicine.
"Indeed, it’s vital to help us solve some of the workforce pressures the profession is facing globally.
"We will increasingly be using the outputs of AI tools to inform our clinical decisions, and yet the mechanisms and algorithms can be something of a black box of mystery.
“We want to understand the needs of clinicians in understanding how to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"The results will be published and freely accessible.
"Our hope is to encourage a collaborative effort to support veterinary teams with embracing the full potential of AI, yet also providing the safeguards and education to the clinicians applying this technology to their patients.”
The survey is here: https://bit.ly/VetCT_AI_Survey.
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
The ‘Midgeater' device introduced by Calor in 2003 to combat biting midges causing irritation to humans, has now been successfully tested by leading scientists as a monitoring device in the fight against bluetongue.
Leading midge scientist Dr Alison Blackwell, who is the Managing Director of University of Edinburgh based Advanced Pest Solutions, presented her company's findings in her keynote speech to the Royal Entomological Society in Belfast on November 19th.
The current method of trapping midges when monitoring the deadly bluetongue virus is a light trap, but Alison and her team have established that a modified Midgeater can be more effective in catching the main midge species that carry the virus.
Alison said: "During trials this year, we found that Calor fuelled Midgeater traps modified with a simple ‘black' light source and fitted with an octenol / ammonia bait, proved to be far more effective at catching the main species of midge known to carry the bluetongue virus than the light traps which are currently used to monitor midge populations in relation to the disease".
Farmers throughout the UK recently commenced a vaccination programme to protect their animals from the only strain of the bluetongue virus that has so far been encountered in the UK, serotype 8, but there is still a real need to carefully monitor biting midge populations, as other strains of the virus are approaching our shores.
Alison added: "In the last few weeks serotype 1 and serotype 6 have been found in Northern Europe and there are currently no vaccines available in the UK for these types of the bluetongue virus, so it is important that we remain vigilant and monitor midges throughout the UK".
Advanced Pest Solutions have tested their modified Midgeater traps in England and Wales. The English, project which was carried out at a specialist bull breeding facility, also included the use of the Barrfly air curtain, from fellow Scottish business Innovent.
Alison explained: "Innovent's air curtain is designed to prevent midges passing through it into sensitive areas. The insects simply aren't strong enough to fly through the air currents it produces.
"The air curtain, combined with the Calor supplied traps and APS's consultancy and analysis creates a comprehensive ‘assess, protect and stop', midge management system that businesses can use to reduce the exposure to the risks of midge borne diseases."
Ceva Animal Health has introduced Cevazuril, a toltrazuril-based oral solution for the control of diarrhoea in sucking pigs. Cevazuril is a one-dose treatment that comes in two pack sizes, both with dosing pumps, for convenient administration to large or small herds.
Ceva says newborn sucking piglets are especially sensitive to coccidiosis and infection may result in lost daily gain of almost 2kg in the first 28 days, due to diarrhoea. The control of coccidiosis using toltrazuril prevents damage to the intestinal mucosa caused by the developmental stages of Isospora suis, helping to preserve digestive function and maintain optimal growth rate.
Toltrazuril is absorbed very slowly in the intestine for longer-lasting action. It works on all intracellular developmental stages of coccidia and reduces oocyst production, even if administered after the appearance of the first oocysts in the faeces of the host.
According to the company, extensive trials showed that three day old piglets treated with toltazuril at 20mg/kg gained 801 grams at weaning and 1601 grams by the end of the post-weaning period compared to control pigs.
Cevazuril is available in a 250ml pack with a pump or a one litre pack with a multi-dose injector. It complements Ceva's swine portfolio which includes the antimicrobials Cevaxel, Coliscour, Florkem, Marbox, Spectam Scourhalt and Tiamvet.
For further product information contact Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com